Why is Onyx Biotec falling/rising?

As of 25-Jun, Onyx Biotec Ltd's stock price is currently at 52.95, reflecting a decline of 2.75, or 4.94%. The stock has underperformed its sector today by 5.99%, and while it has shown a positive return of 10.31% over the past week and 6.97% over the past month, it has a year-to-date decline of 11.01%. Additionally, the stock's delivery volume has significantly decreased by 62.37% compared to the 5-day average, indicating a drop in investor participation. The stock is trading higher than its 5-day, 20-day, and 50-day moving averages, but lower than its 100-day and 200-day moving averages, suggesting mixed signals regarding its recent performance.
In the broader market context, the Sensex has increased by 1.74% over the past week and 1.58% over the past month, which indicates that Onyx Biotec's short-term performance is significantly lagging behind the benchmark. The year-to-date performance of the Sensex shows a gain of 6.77%, further highlighting the underperformance of Onyx Biotec in comparison to the overall market. The lack of available positive or negative factors in the dashboard does not provide additional insights into the reasons behind the stock's recent decline, leaving the analysis focused on the quantitative performance metrics.